{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:19:36Z","timestamp":1780352376687,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010308"],"award-info":[{"award-number":["2023A1515010308"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["T-A-002"],"award-info":[{"award-number":["T-A-002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370056"],"award-info":[{"award-number":["82370056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["02-408-2203-2106"],"award-info":[{"award-number":["02-408-2203-2106"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jcf.2025.02.005","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T23:01:43Z","timestamp":1739660503000},"page":"446-456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of clinical practice guidelines on treatment of cystic fibrosis: A systematic review"],"prefix":"10.1016","volume":"24","author":[{"given":"Yuting","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mianquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyinjun","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangji","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.jcf.2025.02.005_bib0001","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic Fibrosis: a review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.jcf.2025.02.005_bib0002","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMra2216474","article-title":"Cystic Fibrosis","volume":"389","author":"Grasemann","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jcf.2025.02.005_bib0003","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1378\/chest.113.1.217","article-title":"Lung transplantation in cystic fibrosis: consensus conference statement","volume":"113","author":"Yankaskas","year":"1998","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ppul.1950150311","article-title":"Cystic Fibrosis Foundation consensus conference report on pulmonary complications of cystic fibrosis","volume":"15","author":"Schidlow","year":"1993","journal-title":"Pediatr Pulmonol."},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0005","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"Doring","year":"2000","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.jcf.2025.02.005_bib0006","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0300-2896(03)75430-1","article-title":"Consensus conference: home intravenous antibiotic treatment for cystic fibrosis","volume":"39","author":"Salcedo","year":"2003","journal-title":"Arch Bronconeumol"},{"issue":"Suppl 3","key":"10.1016\/j.jcf.2025.02.005_bib0007","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis."},{"issue":"1 Suppl","key":"10.1016\/j.jcf.2025.02.005_bib0008","doi-asserted-by":"crossref","first-page":"1s","DOI":"10.1378\/chest.125.1_suppl.1S","article-title":"Cystic fibrosis adult care: consensus conference report","volume":"125","author":"Yankaskas","year":"2004","journal-title":"Chest."},{"key":"10.1016\/j.jcf.2025.02.005_bib0009","unstructured":"Gjevre J., Jeanneret A., Kovesi T., Lands L., Solomon M., Wilcox P. Canadian consensus statement on aerosolized antibiotic use in cystic fibrosis. 2006."},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2025.02.005_bib0010","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2007.10.001","article-title":"Guidelines for the management of pregnancy in women with cystic fibrosis","volume":"7","author":"Edenborough","year":"2008","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0011","first-page":"522","article-title":"Cystic fibrosis pulmonary guidelines: airway clearance therapies","volume":"54","author":"Flume","year":"2009","journal-title":"Respir Care"},{"issue":"6 Suppl","key":"10.1016\/j.jcf.2025.02.005_bib0012","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2009.04.005","article-title":"Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus","volume":"8","author":"Heijerman","year":"2009","journal-title":"J Cyst Fibros"},{"issue":"9","key":"10.1016\/j.jcf.2025.02.005_bib0014","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1164\/rccm.200812-1845PP","article-title":"Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations","volume":"180","author":"Flume","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1164\/rccm.201002-0157OC","article-title":"Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax","volume":"182","author":"Flume","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcf.2010.04.008","article-title":"Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening","volume":"9","author":"Sermet-Gaudelus","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"Suppl 1","key":"10.1016\/j.jcf.2025.02.005_bib0017","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2025.02.005_bib0018","unstructured":"Excellence NIfHaC. Mannitol dry powder for inhalation for treating cystic fibrosis. https:\/\/www.nice.org.uk\/guidance\/ta266; 2024 [accessed 15 January 2024]."},{"key":"10.1016\/j.jcf.2025.02.005_bib0019","unstructured":"Excellence NIfHaC. Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis. https:\/\/www.nice.org.uk\/guidance\/ta276; 2024 [accessed 15 January 2024]."},{"issue":"7","key":"10.1016\/j.jcf.2025.02.005_bib0020","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2025.02.005_bib0021","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1513\/AnnalsATS.201404-166OC","article-title":"Cystic Fibrosis Foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection","volume":"11","author":"Mogayzel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2025.02.005_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/621342","article-title":"Practical guidelines: lung transplantation in patients with cystic fibrosis","volume":"2014","author":"Hirche","year":"2014","journal-title":"Pulm Med"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1784","article-title":"Clinical practice guidelines from the Cystic Fibrosis Foundation for preschoolers with Cystic Fibrosis","volume":"137","author":"Lahiri","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0024","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/resp.12764","article-title":"Physiotherapy for cystic fibrosis in Australia and New Zealand: a clinical practice guideline","volume":"21","author":"Button","year":"2016","journal-title":"respirol"},{"issue":"7","key":"10.1016\/j.jcf.2025.02.005_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.healun.2021.04.011","article-title":"Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients","volume":"40","author":"Shah","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jcf.2025.02.005_bib0026","unstructured":"Excellence NIfHaC. Lumacaftor\u2013ivacaftor for treating cystic fibrosis homozygous for the F508del mutation. https:\/\/www.nice.org.uk\/guidance\/ta398; 2024 [accessed 15 January 2024]."},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0027","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/s1806-37562017000000065","article-title":"Brazilian guidelines for the diagnosis and treatment of cystic fibrosis","volume":"43","author":"Athanazio","year":"2017","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.jcf.2025.02.005_bib0028","series-title":"The south african cystic fibrosis consensus guidelines. vol 5th editor","author":"Association","year":"2017"},{"key":"10.1016\/j.jcf.2025.02.005_bib0029","unstructured":"Excellence NIfHaC. Cystic fibrosis: diagnosis and management NICE guideline [NG78]. https:\/\/www.nice.org.uk\/guidance\/ng78; 2024 [accessed 15 January 2024]."},{"issue":"2","key":"10.1016\/j.jcf.2025.02.005_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0031","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1513\/AnnalsATS.201707-539OT","article-title":"Cystic fibrosis foundation pulmonary guidelines. Use of cystic fibrosis transmembrane conductance regulator modulator therapy in patients with Cystic fibrosis","volume":"15","author":"Ren","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0032","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcf.2020.02.015","article-title":"Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease","volume":"19","author":"Kapnadak","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2025.02.005_bib0033","doi-asserted-by":"crossref","DOI":"10.5603\/ARM.a2021.0107","article-title":"Nebulisation therapy in patients with cystic fibrosis - consensus of the Polish Cystic Fibrosis Society","author":"Walicka-Serzysko","year":"2021","journal-title":"Adv Respir Med"},{"key":"10.1016\/j.jcf.2025.02.005_bib0034","unstructured":"The Subspecialty Group of Respiratory Diseases tSoP, Chinese Medical Association , Collaboration Group of Rare Disease tSGoRD, the Society of Pediatrics, Chinese Medical Association , Diseases CNCRCoR, Beijing Children 's Hospital CMU. Expert consensus on the diagnosis and treatment of cystic fibrosis in Chinese children. 2022(22):1681\u20137."},{"issue":"1","key":"10.1016\/j.jcf.2025.02.005_bib0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcf.2022.10.002","article-title":"Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis","volume":"22","author":"Southern","year":"2023","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.02.005_bib0036","article-title":"Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association)","volume":"49","author":"Athanazio","year":"2023","journal-title":"J Bras Pneumol"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0037","first-page":"352","article-title":"Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis","volume":"46","year":"2023","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"10.1016\/j.jcf.2025.02.005_bib0038","series-title":"Clinical Practice Guidelines We Can Trust","article-title":"Developing Trustworthy Clinical Practice Guidelines","author":"Graham","year":"2011"},{"issue":"21","key":"10.1016\/j.jcf.2025.02.005_bib0039","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1301725","article-title":"Risk factors for bronchiectasis in children with cystic fibrosis","volume":"368","author":"Sly","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2025.02.005_bib0040","unstructured":"Consortium A.N.S. The AGREE II instrument [Electronic version]. 2017."},{"issue":"12","key":"10.1016\/j.jcf.2025.02.005_bib0041","article-title":"Standards of nutritional care for patients with Cystic Fibrosis: a methodological primer and AGREE II analysis of guidelines","volume":"8","author":"Grammatikopoulou","year":"2021","journal-title":"Children (Basel)"},{"key":"10.1016\/j.jcf.2025.02.005_bib0042","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"18","key":"10.1016\/j.jcf.2025.02.005_bib0043","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0044","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.chest.2016.04.028","article-title":"A critical review of the quality of Cough clinical practice guidelines","volume":"150","author":"Jiang","year":"2016","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jcf.2025.02.005_bib0045","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jclinepi.2010.07.001","article-title":"AGREE II: advancing guideline development, reporting and evaluation in health care","volume":"63","author":"Brouwers","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.jcf.2025.02.005_bib0046","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcf.2025.02.005_bib0047","first-page":"1","article-title":"Protecting and promoting editorial independence","author":"Bhui","year":"2024","journal-title":"Br J Psychiatry : J Mental Sci"},{"issue":"9","key":"10.1016\/j.jcf.2025.02.005_bib0048","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1503\/cmaj.061181","article-title":"Sources of bias for authors of clinical practice guidelines","volume":"175","author":"Detsky","year":"2006","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.jcf.2025.02.005_bib0049","first-page":"685","article-title":"How to address conflicts of interest in clinical practice guidelines","volume":"10","author":"Yaolong","year":"2019","journal-title":"Medical J Pek Union Med College Hospital"},{"issue":"6","key":"10.1016\/j.jcf.2025.02.005_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/EJA.0000000000000603","article-title":"Clinical guidelines: how can we improve adherence and implementation?","volume":"34","author":"Baron","year":"2017","journal-title":"Eur J Anaesthesiol"},{"issue":"7","key":"10.1016\/j.jcf.2025.02.005_bib0051","first-page":"771","article-title":"Methodology for clinical practice guidelines-external review of guidelines prior to publication","volume":"11","author":"Liming","year":"2019","journal-title":"Chinese J Evid-Bases Cardiovascular Med"},{"key":"10.1016\/j.jcf.2025.02.005_bib0052","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1748-5908-9-3","article-title":"Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks","volume":"9","author":"Vernooij","year":"2014","journal-title":"Implement Sci"},{"issue":"6","key":"10.1016\/j.jcf.2025.02.005_bib0053","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1007\/s11999-014-3530-0","article-title":"High methodologic quality but poor applicability: assessment of the AAOS guidelines using the AGREE II instrument","volume":"472","author":"Sabharwal","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10.1016\/j.jcf.2025.02.005_bib0054","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/intqhc\/mzv115","article-title":"Guide to clinical practice guidelines: the current state of play","volume":"28","author":"Kredo","year":"2016","journal-title":"Int J Quality Health Care: J Int Society Quality Health Care"},{"key":"10.1016\/j.jcf.2025.02.005_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1748-5908-4-54","article-title":"Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners","volume":"4","author":"Lugtenberg","year":"2009","journal-title":"Implement Sci"},{"key":"10.1016\/j.jcf.2025.02.005_bib0056","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gerinurse.2023.12.012","article-title":"Pilot testing implementation of the pain management clinical practice guideline in nursing homes","volume":"56","author":"Resnick","year":"2024","journal-title":"Geriatric Nurs (New York, NY)"},{"key":"10.1016\/j.jcf.2025.02.005_bib0057","doi-asserted-by":"crossref","first-page":"13","DOI":"10.18332\/tid\/85944","article-title":"Tobacco treatment Guideline for high risk groups: a pilot study in patients with Chronic obstructive pulmonary disease","volume":"16","author":"Trofor","year":"2018","journal-title":"Tob Induc Dis"},{"issue":"2","key":"10.1016\/j.jcf.2025.02.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007047","article-title":"Do guidelines offer implementation advice to target users? A systematic review of guideline applicability","volume":"5","author":"Gagliardi","year":"2015","journal-title":"BMJ open"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0059","article-title":"Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis","volume":"5","author":"Main","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"issue":"9","key":"10.1016\/j.jcf.2025.02.005_bib0060","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/ppul.23218","article-title":"Influence of respiratory physiotherapy on gastro-oesophageal reflux in infants: a systematic review","volume":"50","author":"Van Ginderdeuren","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2025.02.005_bib0061","article-title":"Autogenic drainage for airway clearance in cystic fibrosis","volume":"12","author":"Burnham","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2025.02.005_bib0062","article-title":"Active cycle of breathing technique for cystic fibrosis","volume":"2","author":"Wilson","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.jcf.2025.02.005_bib0063","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01689-2023","article-title":"Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)","volume":"63","author":"Spinou","year":"2024","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0064","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.chest.2020.06.050","article-title":"Airway clearance techniques in bronchiectasis: analysis from the United States bronchiectasis and non-TB mycobacteria research registry","volume":"158","author":"Basavaraj","year":"2020","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jcf.2025.02.005_bib0065","article-title":"Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis","volume":"2019","author":"McIlwaine","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2025.02.005_bib0066","article-title":"Inhaled corticosteroids for cystic fibrosis","volume":"7","author":"Balfour-Lynn","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0067","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.00077210","article-title":"Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis","volume":"37","author":"De Boeck","year":"2011","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0068","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3906\/sag-1509-101","article-title":"Effect of inhaled steroids on clinical and inflammatoryparameters in children with cystic fibrosis","volume":"47","author":"Uyan","year":"2017","journal-title":"Turk J Med Sci"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0069","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1513\/AnnalsATS.202401-118ED","article-title":"STOP using corticosteroids in cystic fibrosis pulmonary exacerbations","volume":"21","author":"Parkins","year":"2024","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.jcf.2025.02.005_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1164\/rccm.201107-1174CI","article-title":"Corticosteroids in respiratory diseases in children","volume":"185","author":"de Benedictis","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"10.1016\/j.jcf.2025.02.005_bib0071","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJM199503303321303","article-title":"Effect of high-dose ibuprofen in patients with cystic fibrosis","volume":"332","author":"Konstan","year":"1995","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jcf.2025.02.005_bib0072","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009779","article-title":"Antibiotic and anti-inflammatory therapies for cystic fibrosis","volume":"3","author":"Chmiel","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"22","key":"10.1016\/j.jcf.2025.02.005_bib0073","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.2165\/00003495-200363220-00015","article-title":"Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis","volume":"63","author":"Cheer","year":"2003","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jcf.2025.02.005_bib0074","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1183\/09031936.04.00084304","article-title":"Azithromycin for cystic fibrosis","volume":"24","author":"Southern","year":"2004","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2025.02.005_bib0075","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1378\/chest.07-1631","article-title":"Airway inflammation in cystic fibrosis","volume":"133","author":"Elizur","year":"2008","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0076","first-page":"CD001912","article-title":"Prophylactic antibiotics for cystic fibrosis","author":"Smyth","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcf.2025.02.005_bib0077","article-title":"Prophylactic anti-staphylococcal antibiotics for cystic fibrosis","volume":"9","author":"Rosenfeld","year":"2020","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0078","article-title":"Dornase alfa for cystic fibrosis","volume":"3","author":"Yang","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"issue":"10","key":"10.1016\/j.jcf.2025.02.005_bib0079","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2165\/11208950-000000000-00000","article-title":"Mannitol dry powder for inhalation: in patients with cystic fibrosis","volume":"72","author":"Burness","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jcf.2025.02.005_bib0080","article-title":"Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)","volume":"11","author":"Heneghan","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0081","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2025.02.005_bib0082","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1513\/pats.2009008-088TL","article-title":"Lung transplantation for cystic fibrosis","volume":"6","author":"Adler","year":"2009","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jcf.2025.02.005_bib0083","article-title":"Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis","volume":"6","author":"Saldanha","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jcf.2025.02.005_bib0084","first-page":"367","article-title":"How to correctly understand, develop, and apply clinical practice guidelines","volume":"9","author":"Yaolong","year":"2018","journal-title":"Med J Pek Union Med College Hospital"},{"issue":"2","key":"10.1016\/j.jcf.2025.02.005_bib0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.mayocp.2023.03.003","article-title":"Clinical trials for special populations: children, older adults, and rare diseases","volume":"99","author":"Jacobson","year":"2024","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.jcf.2025.02.005_bib0086","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmjebm-2017-110844","article-title":"Different knowledge, different styles of reasoning: a challenge for guideline development","volume":"23","author":"Wieringa","year":"2018","journal-title":"BMJ Evidence-Based Med"},{"issue":"6","key":"10.1016\/j.jcf.2025.02.005_bib0087","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jep.13659","article-title":"Evidence-basing for quality improvement; bringing clinical practice guidelines closer to their promise of improving care practices","volume":"28","author":"Moleman","year":"2022","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.jcf.2025.02.005_bib0088","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1748-5908-7-109","article-title":"Strategies for monitoring and updating clinical practice guidelines: a systematic review","volume":"7","author":"Mart\u00ednez Garc\u00eda","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/j.jcf.2025.02.005_bib0089","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1748-5908-3-45","article-title":"Development of evidence-based clinical practice guidelines (CPGs): comparing approaches","volume":"3","author":"Turner","year":"2008","journal-title":"Implement Sci"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199325000542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:09:12Z","timestamp":1762553352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199325000542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1569199325000542"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.02.005","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of clinical practice guidelines on treatment of cystic fibrosis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}